Pfizer’s gene therapy for hemophilia A succeeds in late-stage trial
Kena Betancur | Corbis News | Getty ImagesPfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval.The treatment for hemophilia A could become the company's second gene therapy to enter the U.S....